PfSPZ Challenge (NF54): Clinical Trials

5 trials of PfSPZ Challenge (NF54), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting, 1 recruiting. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Not yet recruiting 2, Recruiting 1
Phase 21Not yet recruiting 1

Follow PfSPZ Challenge (NF54): new trials by email Literature Review of PfSPZ Challenge (NF54) trials Research Report on PfSPZ Challenge (NF54)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Malaria CVD 36000; Gates INV090205
PfSPZ Challenge (NF54), Wearable Biosensor Devices, Placebo - Malaria (Plasmodium Falciparum)
Phase 1Not yet recruitingUniversity of Maryland, Baltimore322026-11-012026-09-09
Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults
Normal Saline (Placebo), PfSPZ-LARC2 Vaccine, PfSPZ Challenge (NF54) - Malaria Falciparum
Phase 1RecruitingSanaria Inc.582026-03-122026-06-22
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
Pyronaridine Tetraphosphate, Artesunate Drug Combination, PfSPZ Challenge (NF54), MVA ME-TRAP - Malaria
Phase 1 / Phase 2Not yet recruitingUniversity Hospital Tuebingen302025-06-012024-12-06
Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis
atovaquone/proguanil 250mg/100mg (A/P), PfSPZ Challenge (NF54), NaCl 0,9% - Malaria
Phase 1CompletedUniversity Hospital Tuebingen302016-11-282019-07-15
Sequential Optimization of Dose and Schedule of PfSPZ Vaccine
PfSPZ Vaccine, PfSPZ Challenge (NF54), PfSPZ Challenge (7G8) - Malaria
Phase 1CompletedSanaria Inc.452016-08-292019-02-01

Conditions studied

Malaria (4)  ·  Malaria, Falciparum (3)

Sponsors

Sanaria Inc. (2)  ·  University Hospital Tuebingen (2)  ·  University of Maryland, Baltimore (1)

Countries

Germany (2)  ·  United States (1)

Top investigators

Peter G Kremsner, Prof (1)  ·  Peter Kremsner, MD (1)

Results publications

PMID 35999221, PMID 37384799

NIH funding

2015 (1)